Clinical Trial Detail

NCT ID NCT03826992
Title Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Children's Hospital Medical Center, Cincinnati
Indications

acute leukemia

acute lymphoblastic leukemia

acute myeloid leukemia

Therapies

CPX-351 + Venetoclax

Age Groups: child adult

Additional content available in CKB BOOST